Financial Snapshot
Revenues
Revenues
Revenue YoY Change
Revenues
Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $832.0K | $10.26M | $1.775M | $7.411M | $4.112M | $30.48M | $42.22M | $35.37M | $40.57M | $10.46M | $13.47M | $4.119M | $9.795M | $6.145M | $9.120M | $2.100M | $4.810M | $3.470M | $5.470M | $1.170M | $80.00K | $190.0K | $110.0K | $4.290M | $5.080M | $8.320M | $3.230M | $3.090M | $2.620M |
YoY Change | -91.89% | 478.23% | -76.05% | 80.24% | -86.51% | -27.8% | 19.37% | -12.83% | 288.0% | -22.35% | 226.98% | -57.95% | 59.41% | -32.62% | 334.29% | -56.34% | 38.62% | -36.56% | 367.52% | 1362.5% | -57.89% | 72.73% | -97.44% | -15.55% | -38.94% | 157.59% | 4.53% | 17.94% |
Expenses
Cost Of Revenues
Gross Profit
Gross Profit Margin
Gross Profit
Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $832.0K | $10.26M | $1.775M | $7.411M | $4.112M | $30.48M | $42.22M | $35.37M | $40.57M | $10.46M | $13.47M | $4.119M | $9.795M | $6.145M | $9.120M | $2.100M | $4.810M | $3.470M | $5.470M | $1.170M | $80.00K | $190.0K | $110.0K | $4.290M | $5.080M | $8.320M | $3.230M | $3.090M | $2.620M |
Cost Of Revenue | $2.020M | $1.640M | $1.430M | $1.280M | $950.0K | ||||||||||||||||||||||||
Gross Profit | $3.050M | $6.680M | $1.800M | $1.810M | $1.670M | ||||||||||||||||||||||||
Gross Profit Margin | 60.04% | 80.29% | 55.73% | 58.58% | 63.74% |
Selling, General & Admin Expense
Research & Development
Depreciation, Depletion & Amortization
SGA Expense to Gross Profit Ratio
R&D To Gross Profit Ratio
DDA To Gross Profit Ratio
Operating Expenses Total
Operating Profits/Loss
Operational Expenses
Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General & Admin | $47.58M | $90.19M | $53.75M | $37.25M | $27.20M | $29.32M | $28.29M | $23.89M | $18.06M | $15.86M | $12.97M | $10.78M | $11.99M | $12.11M | $13.67M | $10.01M | $11.08M | $8.310M | $5.980M | $6.130M | $4.570M | $3.660M | $3.970M | $4.440M | $6.400M | $5.480M | $4.170M | $2.660M | $2.110M |
YoY Change | -47.24% | 67.78% | 44.3% | 36.95% | -7.23% | 3.64% | 18.42% | 32.28% | 13.87% | 22.28% | 20.32% | -10.09% | -0.99% | -11.41% | 36.56% | -9.66% | 33.33% | 38.96% | -2.45% | 34.14% | 24.86% | -7.81% | -10.59% | -30.63% | 16.79% | 31.41% | 56.77% | 26.07% | |
% of Gross Profit | 209.84% | 82.04% | 231.67% | 146.96% | 126.35% | ||||||||||||||||||||||||
Research & Development | $86.68M | $187.7M | $249.2M | $94.25M | $88.02M | $95.26M | $98.57M | $88.71M | $57.79M | $34.10M | $21.37M | $17.98M | $20.03M | $13.26M | $9.410M | $5.750M | $9.630M | $8.510M | $11.46M | $6.550M | $2.150M | $2.470M | $2.080M | $5.150M | $7.890M | $8.090M | $5.640M | $2.200M | $1.500M |
YoY Change | -53.81% | -24.71% | 164.46% | 7.08% | -7.6% | -3.36% | 11.12% | 53.5% | 69.5% | 59.56% | 18.81% | -10.22% | 51.11% | 40.88% | 63.65% | -40.29% | 13.16% | -25.74% | 74.96% | 204.65% | -12.96% | 18.75% | -59.61% | -34.73% | -2.47% | 43.44% | 156.36% | 46.67% | |
% of Gross Profit | 258.69% | 121.11% | 313.33% | 121.55% | 89.82% | ||||||||||||||||||||||||
Depreciation & Amortization | $2.600M | $3.700M | $3.000M | $3.000M | $3.600M | $3.700M | $1.850M | $1.708M | $1.048M | $626.6K | $328.8K | $173.8K | $142.2K | $194.6K | $1.680M | $1.000M | $1.020M | $980.0K | $860.0K | $570.0K | $580.0K | $620.0K | $530.0K | $620.0K | $570.0K | $410.0K | $250.0K | $170.0K | $100.0K |
YoY Change | -29.73% | 23.33% | 0.0% | -16.67% | -2.7% | 99.96% | 8.3% | 62.96% | 67.33% | 90.59% | 89.21% | 22.19% | -26.94% | -88.41% | 68.0% | -1.96% | 4.08% | 13.95% | 50.88% | -1.72% | -6.45% | 16.98% | -14.52% | 8.77% | 39.02% | 64.0% | 47.06% | 70.0% | |
% of Gross Profit | 18.69% | 6.14% | 13.89% | 9.39% | 5.99% | ||||||||||||||||||||||||
Operating Expenses | $144.8M | $277.8M | $303.0M | $131.5M | $115.2M | $124.6M | $125.9M | $111.6M | $74.86M | $49.95M | $33.01M | $27.61M | $31.43M | $25.36M | $23.08M | $15.76M | $20.71M | $16.82M | $17.64M | $12.68M | $6.710M | $6.120M | $6.050M | $9.580M | $14.29M | $13.57M | $9.810M | $4.860M | $3.600M |
YoY Change | -47.89% | -8.3% | 130.42% | 14.12% | -7.51% | -1.02% | 12.78% | 49.09% | 49.85% | 51.32% | 19.55% | -12.16% | 23.93% | 9.9% | 46.45% | -23.9% | 23.13% | -4.65% | 39.12% | 88.97% | 9.64% | 1.16% | -36.85% | -32.96% | 5.31% | 38.33% | 101.85% | 35.0% | |
Operating Profit | -$143.9M | -$267.6M | -$301.2M | -$124.1M | -$111.1M | -$94.09M | -$83.64M | -$76.24M | -$34.28M | -$39.50M | -$19.54M | -$23.49M | -$21.64M | -$19.22M | -$11.24M | -$6.890M | -$8.010M | -$3.050M | -$1.930M | ||||||||||
YoY Change | -46.21% | -11.17% | 142.76% | 11.68% | 18.09% | 12.49% | 9.72% | 122.37% | -13.2% | 102.08% | -16.81% | 8.57% | 12.58% | 63.13% | -13.98% | 162.62% | 58.03% |
Interest Expenses
Interest Expenses To Operating Income %
Other Expense/Income
Interest & Other Expense/Income
Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Interest Expense | $1.223M | $1.254M | $1.936M | $8.702M | $7.949M | $0.00 | $25.93K | $2.500M | $3.080M | $3.360M | -$46.86M | $3.780M | $6.330M | $1.580M | -$10.50M | $690.0K | $4.690M | $1.000M | $210.0K | $250.0K | $50.00K | $30.00K | $90.00K | $350.0K | $530.0K | $280.0K | $410.0K | $50.00K | $60.00K |
YoY Change | -2.49% | -35.24% | -77.75% | 9.48% | -100.0% | -98.96% | -18.83% | -8.33% | -107.17% | -1339.68% | -40.28% | 300.63% | -115.05% | -1621.74% | -85.29% | 369.0% | 376.19% | -16.0% | 400.0% | 66.67% | -66.67% | -74.29% | -33.96% | 89.29% | -31.71% | 720.0% | -16.67% | ||
% of Operating Profit | |||||||||||||||||||||||||||||
Other Income/Expense, Net | -$4.712M | -$3.862M | $343.4K | -$704.9K | $496.2K | -$1.344M | -$197.5K | ||||||||||||||||||||||
YoY Change | 22.01% | -1224.61% | -148.71% | -242.06% | -136.92% | 580.28% |
Income/Loss
Pretax Income
Income Tax
Net Profits/Loss
Pretax Income YoY Change
Income Tax Rate
Net Profits/Loss YoY Change
Basic EPS
Net Income To Revenue Ratio
Pretax & Net Income
Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pretax Income | -$135.1M | -$277.7M | -$303.2M | -$162.9M | -$120.8M | -$94.80M | -$88.21M | -$73.74M | -$31.20M | -$36.14M | -$66.08M | -$19.71M | -$15.30M | -$17.64M | -$24.46M | -$12.97M | -$11.21M | -$12.34M | -$15.30M | -$11.26M | -$6.590M | -$5.910M | -$5.850M | -$4.940M | -$10.70M | -$6.600M | -$7.600M | -$2.990M | -$1.880M |
YoY Change | -51.34% | -8.43% | 86.15% | 34.83% | 27.44% | 7.47% | 19.62% | 136.34% | -13.67% | -45.31% | 235.28% | 28.82% | -13.27% | -27.88% | 88.59% | 15.7% | -9.16% | -19.35% | 35.88% | 70.86% | 11.51% | 1.03% | 18.42% | -53.83% | 62.12% | -13.16% | 154.18% | 59.04% | |
Income Tax | $0.00 | $0.00 | $0.00 | $0.00 | -$257.0K | $2.170M | $0.00 | $0.00 | -$2.100M | $0.00 | $0.00 | $30.00K | $27.00K | $71.00K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
% Of Pretax Income | |||||||||||||||||||||||||||||
Net Earnings | -$135.1M | -$279.8M | -$303.7M | -$166.4M | -$119.4M | -$96.97M | -$88.21M | -$73.74M | -$29.19M | -$36.12M | -$66.03M | -$19.67M | -$15.25M | -$17.61M | -$24.41M | -$12.97M | -$11.21M | -$12.34M | -$15.30M | -$10.97M | -$4.660M | -$5.960M | -$6.360M | -$8.870M | -$10.70M | -$7.150M | -$7.910M | -$3.330M | -$2.030M |
YoY Change | -51.72% | -7.87% | 82.5% | 39.42% | 23.09% | 9.93% | 19.62% | 152.64% | -19.2% | -45.29% | 235.7% | 28.95% | -13.4% | -27.84% | 88.2% | 15.7% | -9.16% | -19.35% | 39.47% | 135.41% | -21.81% | -6.29% | -28.3% | -17.1% | 49.65% | -9.61% | 137.54% | 64.04% | |
Net Earnings / Revenue | -16237.79% | -2726.49% | -17112.19% | -2245.39% | -2902.75% | -318.12% | -208.92% | -208.49% | -71.94% | -345.44% | -490.29% | -477.56% | -155.72% | -286.65% | -267.65% | -617.62% | -233.06% | -355.62% | -279.71% | -937.61% | -5825.0% | -3136.84% | -5781.82% | -206.76% | -210.63% | -85.94% | -244.89% | -107.77% | -77.48% |
Basic Earnings Per Share | -$6.09 | -$1.17 | -$1.45 | -$1.07 | -$1.21 | -$1.05 | -$1.08 | -$1.01 | -$0.43 | -$0.61 | -$1.43 | -$0.58 | |||||||||||||||||
Diluted Earnings Per Share | -$6.09 | -$1.17 | -$1.45 | -$1.07 | -$1.21 | -$1.05 | -$1.09 | -$1.01 | -$0.44 | -$0.64 | -$1.43 | -$0.58 | -$483.2K | -$682.6K | -$1.307M | -$1.181M | -$1.081M | -$1.566M | -$3.221M | -$2.488M | -$1.399M | -$2.346M | -$3.014M | -$5.127M | -$7.754M | -$5.630M | -$7.126M | -$4.215M | -$2.900M |
Assets & Liabilities
Cash & Short-Term Investments
Cash & Equivalents
Cash To Operating Expenses Ratio
Inventory
Receivables
Total Short-Term Assets
Property, Plant And Equipment
Long-Term Investments
Total Long-Term Assets
Total Assets
Net Income To Total Assets Percentage
Accounts Payable
Short-Term Debt
Long Term Debt Due
Total Short-Term Liabilities
Long-Term Debt
Other Long-Term Liabilities
Total Long-Term Liabilities
Total Liabilities
Short-Term To Long-Term Debt Ratio
Short-Term Assets To Debt Ratio
Long-Term Debt To Net Income Ratio
Assets & Liabilities
Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Short-Term Investments | $145.3M | $253.0M | $401.3M | $411.6M | $89.50M | $81.20M | $127.4M | $104.8M | $163.0M | $93.60M | $52.60M | $13.70M | $30.20M | $21.80M | $40.70M | $14.10M | $27.30M | $23.00M | $17.20M | $17.90M | $13.50M | $900.0K | $1.800M | $6.500M | $9.700M | $6.200M | $6.500M | $1.800M | |
YoY Change | -42.57% | -36.96% | -2.5% | 359.89% | 10.22% | -36.26% | 21.56% | -35.71% | 74.15% | 77.95% | 283.94% | -54.64% | 38.53% | -46.44% | 188.65% | -48.35% | 18.7% | 33.72% | -3.91% | 32.59% | 1400.0% | -50.0% | -72.31% | -32.99% | 56.45% | -4.62% | 261.11% | ||
Cash & Equivalents | $14.31M | $46.33M | $71.14M | $250.7M | $22.20M | $23.70M | $23.80M | $19.10M | $57.60M | $40.50M | $33.70M | $5.600M | $17.40M | $20.00M | $30.30M | $14.10M | $10.30M | $8.300M | $17.20M | $17.90M | $13.50M | $900.0K | $1.800M | $3.700M | $9.700M | $6.200M | $6.500M | $1.800M | |
Short-Term Investments | $131.0M | $206.7M | $330.2M | $160.9M | $67.30M | $57.50M | $103.6M | $85.60M | $105.4M | $53.10M | $18.90M | $8.000M | $12.90M | $1.800M | $10.40M | $0.00 | $17.00M | $14.70M | $0.00 | $2.800M | $0.00 | ||||||||
Other Short-Term Assets | $5.414M | $50.51M | $39.10M | $40.50M | $2.600M | $2.500M | $4.400M | $3.300M | $1.500M | $2.500M | $2.800M | $1.500M | $1.200M | $900.0K | $3.500M | $500.0K | $600.0K | $1.100M | $900.0K | $100.0K | $100.0K | $1.700M | $1.700M | $100.0K | $100.0K | $0.00 | $0.00 | $0.00 | |
YoY Change | -89.28% | 29.18% | -3.46% | 1457.69% | 4.0% | -43.18% | 33.33% | 120.0% | -40.0% | -10.71% | 86.67% | 25.0% | 33.33% | -74.29% | 600.0% | -16.67% | -45.45% | 22.22% | 800.0% | 0.0% | -94.12% | 0.0% | 1600.0% | 0.0% | |||||
Inventory | $800.0K | $600.0K | $700.0K | $400.0K | $400.0K | ||||||||||||||||||||||||
Prepaid Expenses | |||||||||||||||||||||||||||||
Receivables | $0.00 | $1.702M | $5.467M | $18.60M | $700.0K | $3.300M | $6.000M | $15.80M | $7.300M | $2.800M | $3.300M | $800.0K | $500.0K | $0.00 | $300.0K | $700.0K | $1.100M | $300.0K | $300.0K | $400.0K | $200.0K | $100.0K | $200.0K | $900.0K | $1.100M | $800.0K | $500.0K | $700.0K | |
Other Receivables | $2.405M | $10.04M | $2.565M | $500.0K | $1.300M | $800.0K | $500.0K | $800.0K | $0.00 | $0.00 | $0.00 | $100.0K | $0.00 | $100.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
Total Short-Term Assets | $153.1M | $315.2M | $448.4M | $471.2M | $94.20M | $87.80M | $138.4M | $124.6M | $171.9M | $98.90M | $58.70M | $16.00M | $31.90M | $22.90M | $44.60M | $15.30M | $29.00M | $24.50M | $18.30M | $18.40M | $13.80M | $2.700M | $3.700M | $8.300M | $11.60M | $7.600M | $7.400M | $3.000M | |
YoY Change | -51.43% | -29.7% | -4.83% | 400.21% | 7.29% | -36.56% | 11.08% | -27.52% | 73.81% | 68.48% | 266.88% | -49.84% | 39.3% | -48.65% | 191.5% | -47.24% | 18.37% | 33.88% | -0.54% | 33.33% | 411.11% | -27.03% | -55.42% | -28.45% | 52.63% | 2.7% | 146.67% | ||
Property, Plant & Equipment | $14.45M | $17.96M | $29.02M | $24.10M | $26.60M | $15.90M | $18.30M | $9.000M | $7.300M | $4.600M | $2.900M | $400.0K | $300.0K | $300.0K | $300.0K | $400.0K | $400.0K | $400.0K | $400.0K | $200.0K | $200.0K | $300.0K | $600.0K | $900.0K | $1.000M | $1.200M | $1.000M | $700.0K | |
YoY Change | -19.51% | -38.13% | 20.43% | -9.4% | 67.3% | -13.11% | 103.33% | 23.29% | 58.7% | 58.62% | 625.0% | 33.33% | 0.0% | 0.0% | -25.0% | 0.0% | 0.0% | 0.0% | 100.0% | 0.0% | -33.33% | -50.0% | -33.33% | -10.0% | -16.67% | 20.0% | 42.86% | ||
Goodwill | |||||||||||||||||||||||||||||
YoY Change | |||||||||||||||||||||||||||||
Intangibles | |||||||||||||||||||||||||||||
YoY Change | |||||||||||||||||||||||||||||
Long-Term Investments | $2.780M | $2.007M | $3.907M | $4.900M | $6.300M | $9.400M | $11.40M | $19.80M | $20.00M | $12.30M | $9.700M | $10.70M | $9.100M | $11.40M | $12.30M | $9.200M | $0.00 | ||||||||||||
YoY Change | 38.52% | -48.62% | -20.27% | -22.22% | -32.98% | -17.54% | -42.42% | -1.0% | 62.6% | 26.8% | -9.35% | 17.58% | -20.18% | -7.32% | 33.7% | ||||||||||||||
Other Assets | $605.3K | $684.0K | $1.426M | $26.00M | $2.700M | $2.700M | $2.600M | $2.100M | $700.0K | $1.000M | $1.200M | $500.0K | $400.0K | $300.0K | $300.0K | $200.0K | $300.0K | $300.0K | $200.0K | $0.00 | $100.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
YoY Change | -11.51% | -52.02% | -94.52% | 862.96% | 0.0% | 3.85% | 23.81% | 200.0% | -30.0% | -16.67% | 140.0% | 25.0% | 33.33% | 0.0% | 50.0% | -33.33% | 0.0% | -100.0% | |||||||||||
Total Long-Term Assets | $17.84M | $33.29M | $47.50M | $68.60M | $49.80M | $43.30M | $48.80M | $49.10M | $41.90M | $32.90M | $29.60M | $29.10M | $29.20M | $33.20M | $36.00M | $23.70M | $10.80M | $11.40M | $10.70M | $2.600M | $2.400M | $2.700M | $2.900M | $3.200M | $2.400M | $2.200M | $1.800M | $1.200M | |
YoY Change | -46.42% | -29.91% | -30.76% | 37.75% | 15.01% | -11.27% | -0.61% | 17.18% | 27.36% | 11.15% | 1.72% | -0.34% | -12.05% | -7.78% | 51.9% | 119.44% | -5.26% | 6.54% | 311.54% | 8.33% | -11.11% | -6.9% | -9.37% | 33.33% | 9.09% | 22.22% | 50.0% | ||
Total Assets | $171.0M | $348.5M | $495.9M | $539.8M | $144.0M | $131.1M | $187.2M | $173.7M | $213.8M | $131.8M | $88.30M | $45.10M | $61.10M | $56.10M | $80.60M | $39.00M | $39.80M | $35.90M | $29.00M | $21.00M | $16.20M | $5.400M | $6.600M | $11.50M | $14.00M | $9.800M | $9.200M | $4.200M | |
YoY Change | |||||||||||||||||||||||||||||
Accounts Payable | $4.648M | $65.08M | $24.21M | $800.0K | $6.900M | $10.00M | $7.600M | $5.900M | $4.300M | $2.000M | $6.000M | $900.0K | $1.100M | $700.0K | $3.900M | $400.0K | $1.800M | $2.000M | $1.900M | $2.200M | $800.0K | $1.000M | $800.0K | $1.400M | $1.800M | $1.400M | $1.000M | $600.0K | |
YoY Change | -92.86% | 168.79% | 2926.71% | -88.41% | -31.0% | 31.58% | 28.81% | 37.21% | 115.0% | -66.67% | 566.67% | -18.18% | 57.14% | -82.05% | 875.0% | -77.78% | -10.0% | 5.26% | -13.64% | 175.0% | -20.0% | 25.0% | -42.86% | -22.22% | 28.57% | 40.0% | 66.67% | ||
Accrued Expenses | $21.04M | $29.22M | $36.36M | $32.70M | $17.40M | $15.10M | $16.60M | $12.90M | $6.800M | $5.000M | $1.400M | $3.700M | $4.200M | $2.900M | $300.0K | $1.400M | $600.0K | $700.0K | $1.100M | $2.200M | $0.00 | ||||||||
YoY Change | -27.99% | -19.63% | 11.2% | 87.93% | 15.23% | -9.04% | 28.68% | 89.71% | 36.0% | 257.14% | -62.16% | -11.9% | 44.83% | 866.67% | -78.57% | 133.33% | -14.29% | -36.36% | -50.0% | ||||||||||
Deferred Revenue | |||||||||||||||||||||||||||||
YoY Change | |||||||||||||||||||||||||||||
Short-Term Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $12.10M | $12.10M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
YoY Change | -100.0% | 0.0% | |||||||||||||||||||||||||||
Long-Term Debt Due | $16.77M | $0.00 | $0.00 | $0.00 | $100.0K | $100.0K | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||
YoY Change | -100.0% | 0.0% | |||||||||||||||||||||||||||
Total Short-Term Liabilities | $42.57M | $96.87M | $65.74M | $41.70M | $32.00M | $35.30M | $35.40M | $43.80M | $31.50M | $14.00M | $29.00M | $8.400M | $11.00M | $6.400M | $19.40M | $14.70M | $3.400M | $6.900M | $3.700M | $5.400M | $1.200M | $1.700M | $1.600M | $1.500M | $2.100M | $1.400M | $1.000M | $700.0K | |
YoY Change | -56.05% | 47.35% | 57.65% | 30.31% | -9.35% | -0.28% | -19.18% | 39.05% | 125.0% | -51.72% | 245.24% | -23.64% | 71.88% | -67.01% | 31.97% | 332.35% | -50.72% | 86.49% | -31.48% | 350.0% | -29.41% | 6.25% | 6.67% | -28.57% | 50.0% | 40.0% | 42.86% | ||
Long-Term Debt | $0.00 | $16.61M | $14.96M | $18.70M | $77.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $100.0K | $100.0K | $100.0K | $100.0K | |
YoY Change | -100.0% | 11.06% | -20.0% | -75.71% | -100.0% | 0.0% | 0.0% | 0.0% | |||||||||||||||||||||
Other Long-Term Liabilities | $11.03M | $12.66M | $15.54M | $18.20M | $29.50M | $8.800M | $9.300M | $6.300M | $6.300M | $5.700M | $6.200M | $1.700M | $2.100M | $2.500M | $100.0K | $4.300M | $4.400M | $4.600M | $700.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
YoY Change | -12.83% | -18.55% | -14.62% | -38.31% | 235.23% | -5.38% | 47.62% | 0.0% | 10.53% | -8.06% | 264.71% | -19.05% | -16.0% | 2400.0% | -97.67% | -2.27% | -4.35% | 557.14% | |||||||||||
Total Long-Term Liabilities | $11.03M | $29.27M | $30.50M | $36.90M | $106.5M | $8.800M | $9.300M | $6.300M | $6.300M | $5.700M | $6.200M | $1.700M | $2.100M | $2.500M | $100.0K | $4.300M | $4.400M | $4.600M | $700.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $100.0K | $100.0K | $100.0K | $100.0K | |
YoY Change | -62.31% | -4.03% | -17.35% | -65.35% | 1110.23% | -5.38% | 47.62% | 0.0% | 10.53% | -8.06% | 264.71% | -19.05% | -16.0% | 2400.0% | -97.67% | -2.27% | -4.35% | 557.14% | -100.0% | 0.0% | 0.0% | 0.0% | |||||||
Total Liabilities | $53.60M | $126.2M | $96.27M | $78.60M | $140.5M | $44.20M | $44.80M | $50.40M | $38.20M | $20.60M | $35.80M | $10.80M | $13.80M | $9.600M | $20.10M | $19.90M | $8.700M | $17.80M | $5.500M | $5.400M | $1.200M | $1.700M | $1.700M | $1.600M | $2.200M | $1.600M | $1.100M | $800.0K | |
YoY Change | -57.52% | 31.06% | 22.48% | -44.06% | 217.87% | -1.34% | -11.11% | 31.94% | 85.44% | -42.46% | 231.48% | -21.74% | 43.75% | -52.24% | 1.01% | 128.74% | -51.12% | 223.64% | 1.85% | 350.0% | -29.41% | 0.0% | 6.25% | -27.27% | 37.5% | 45.45% | 37.5% |
Ownership
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares
Stock Issuance & Repurchase
Ownership Data
Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Basic Shares Outstanding | 22.17M shares | 238.6M shares | 208.8M shares | 155.1M shares | 98.72M shares | 92.54M shares | 81.78M shares | 73.21M shares | 68.20M shares | 59.13M shares | 46.09M shares | 34.13M shares | |||||||||||||||||
Diluted Shares Outstanding | 22.17M shares | 238.6M shares | 208.8M shares | 155.1M shares | 98.72M shares | 92.54M shares | 81.92M shares | 73.21M shares | 68.37M shares | 59.41M shares | 46.09M shares | 34.13M shares | |||||||||||||||||
Preferred Stock | |||||||||||||||||||||||||||||
Treasury Stock Shares |
Return On Shareholders' Equity
Book Value
Free Cash Flow
Free Cash Flow YoY
Free Cash Flow Margin
Dividends
Dividends
Stock Price
About INOVIO PHARMACEUTICALS, INC.
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. The company is headquartered in San Diego, California and currently employs 122 full-time employees. The firm is focused on developing and commercializing deoxyribonucleic acid (DNA) medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines pipeline include INO-3107 for HPV-related recurrent respiratory papillomatosis (RRP); INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma, or OPSCC; VGX-3100 for the treatment of Anal or Perianal HSIL; INO-5401 for the treatment of Glioblastoma Multiforme (GBM), and INO-5401 for the Treatment of Glioblastoma Multiforme (GBM). Its lead candidate is INO-3107 for the treatment of RRP, a rare and debilitating disease of the respiratory tract caused by HPV infection. Its DNA medicines platform consists of DNA plasmids and its CELLECTRA devices, which are used to deliver the DNA plasmids into the cell. Its CELLECTRA device portfolio consists of two models.
Industry: Pharmaceutical Preparations Peers: HERON THERAPEUTICS, INC. /DE/ Aura Biosciences, Inc. Organogenesis Holdings Inc. bluebird bio, Inc. C4 Therapeutics, Inc. PRECIGEN, INC. LEXICON PHARMACEUTICALS, INC. Protagonist Therapeutics, Inc Rallybio Corp